The US Food and Drug Administration was largely able to avoid a mass exodus of employees during the COVID-19 pandemic, but many felt recruitment and retention were negatively affected.
Surveys conducted as part of the final assessment of hiring and retention practices in the centers for drug and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?